oxycontin

Nearly half of all U.S. states want a share of a lawsuit settlement with Purdue Pharma to pay for programs to address record overdose deaths and a worsening opioid crisis during the pandemic. We take a look at the impact of the pandemic on addiction treatment and where the recovery community heads from here.

OxyContin maker Purdue Pharma agreed on Monday to pay $4.28 billion to settle lawsuits alleging it helped to create the opioid epidemic.Nearly half of all…

McKinsey is the latest major American corporation to face legal, financial and public relations peril stemming from its role in the nation's deadly opioid epidemic.

The controversial deal hashed out between the Department of Justice and the maker of Oxycontin provides hundreds of millions of dollars of relief for communities hit hard by the opioid epidemic.

According to a court filing Monday, the family pulled about $10.7 billion from Purdue since 2008 — ramping up withdrawals even after executives pleaded guilty to misleading regulators about OxyContin.

The bankruptcy follows the Sackler family, which owns Purdue, agreeing to surrender control of the company and offering $3 billion in cash to opioid-hit communities.

The pending settlement likely means Purdue will avoid going to trial in the sprawling and complicated case involving some 2,300 local governments across 23 states.

As of July 1, the Ohio Bureau of Workers' Compensation will no longer pay for a powerful painkiller that’s at the center of the opioid crisis here in...